These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22363887)

  • 1. Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use.
    Hokken-Koelega A; Keller A; Rakov V; Kipper S; Dahlgren J
    ISRN Endocrinol; 2011; 2011():803948. PubMed ID: 22363887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study.
    Tauber M; Jaquet D; Jesuran-Perelroizen M; Petrus M; Bertrand AM; Coutant R;
    Patient Prefer Adherence; 2013; 7():455-62. PubMed ID: 23737664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Children and adolescent acceptability of a new device system to administer human growth hormone--a pilot study.
    Kappelgaard AM; Mikkelsen S; Bagger C; Fuchs GS
    J Pediatr Endocrinol Metab; 2012; 25(3-4):285-94. PubMed ID: 22768658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey.
    Adachi M
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1105-10. PubMed ID: 23843576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use.
    Dahlgren J; Veimo D; Johansson L; Bech I
    Curr Med Res Opin; 2007 Jul; 23(7):1649-55. PubMed ID: 17559757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
    Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
    Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients.
    Kappelgaard AM; Mikkelsen S; Knudsen TK; Fuchs GS
    J Pediatr Endocrinol Metab; 2011; 24(7-8):489-96. PubMed ID: 21932587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of growth hormone device optimization in patient-reported outcomes: real-world evidence from South Korea.
    Lee JE; Lee KH; Park MJ; Yang S; Kim EY; Rhie YJ; Jung MH; Yang A; Kim SH; Chung LY; Ko SY; Lee YJ; Nedjatian N; Chung WY
    Expert Rev Med Devices; 2021 Jan; 18(1):91-106. PubMed ID: 33307881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.
    Rohrer TR; Winter F; Qvist M; Kappelgaard AM
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1603-12. PubMed ID: 24073645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of injection dose force, accuracy and precision among three growth hormone injection devices.
    Kappelgaard AM; Hansen NÅ
    Expert Rev Med Devices; 2013 May; 10(3):321-7. PubMed ID: 23560872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis.
    Pollock RF; Qian Y; Wisniewski T; Seitz L; Kappelgaard AM
    Med Devices (Auckl); 2013; 6():107-14. PubMed ID: 23946672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicians' Feedback on Patient/Carer Experience After Switching of Growth Hormone Treatment in Pediatric Patients During COVID-19.
    Blair J; Warth K; Suvarna Y; Cappa M
    Patient Prefer Adherence; 2021; 15():2113-2123. PubMed ID: 34584405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations.
    Nickman NA; Haak SW; Kim J
    BMC Nurs; 2010 Apr; 9():6. PubMed ID: 20377905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label acceptability study of Norditropin SimpleXx--a new liquid growth hormone formulation.
    Stanhope R; Buchanan C; Butler G; Costigan C; Dunger D; Greene S; Hoey H; Hughes I; Kelnar C; Kirk J; Komulainen J; Lowry M; Warner J
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):735-40. PubMed ID: 11453523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe.
    Lajara R; Guerrero G; Thurman J
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1181-96. PubMed ID: 22971161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.
    Drent ML; Jakobsdottir S; van Wijk JAE; Oostdijk W; Wit JM
    Clin Drug Investig; 2002 Sep; 22(9):633-638. PubMed ID: 29492857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.